Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2003

View Archived Issues

Role for NMDA receptor antagonists in pain

New data on sertraline in GAD, panic disorder and postpartum depression

Potential use of SM-31900 for treating acute brain ischemia

Pharmacokinetics of HBOC-201 in surgical patients

Effects of etiprednol dicloacetate on the HPA axis

Stiripentol added to carbamazepine effective in refractory partial epilepsy

CVT-3146: tolerability and pharmacokinetics in man

Histone deacetylase inhibitors derived from SAHA presented at ACS meeting

New PTP1B inhibitors in early development at Abbott

Aventis presents four related series of anorectic compounds

Novel N-type calcium channel antagonists prepared and tested at Ajinomoto

Nonsteroidal metal chelators with affinity for steroid receptors for cancer diagnosis and treatment

Nippon Chemiphar claims PPARdelta agonists with utility in metabolic disorders

Hepavir B enters clinical testing

Periostat approved in Canada

Renagel receives NHI drug price listing in Japan

Celmed focuses development activities on Theralux and Neuro technology platforms

Postmarketing Visicol study begins patient treatment

APT-070 enters phase IIa trials

Prous Science announces publication of state-of-the-art review: acne vulgaris

DA-8159 is well tolerated in healthy volunteers and without significant hemodynamic effects

Thirty-five new products reach their first markets in 2002

Potent CCR3 receptor antagonists with potential in chronic inflammation

Merck reports the identification of a surprisingly potent and selective thrombin inhibitor

Thienopyridines targeting VEGFR tyrosine kinase presented by Pfizer

Safety, tolerability and pharmacokinetics of single and multiple oral doses of LY-450108

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....